Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Spyre Therapeutics, Inc. SYRE

Set alert

Price alert · SYRE

All alert types
99.07 USD +3.56 +3.73%

As of Nov 3, 10:46 AM ET

Bid
99.08 × 1
Ask
99.85 × 1
96.51 Day range 100.00
21.15 52-week range 110.18
YTD
+202.41%
1 year
+316.61%
Open
97.04
Prev close
95.51
Mkt cap
9.27B
Vol
106.63K
Avg vol
1.21M
EPS
-1.92
P/E
0.00
Div yield
0.00%
More statistics
Low
96.51
High
100.00
Forward P/E
-26.92
Beta
3.23
Short ratio
7.98
Inst. own
111.16%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
90.06
200-d avg
73.22
1y target
122.33

5D chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 3, 2026Earnings: —; estimate -0.78502; surprise —%
Signals (116)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM1 hour ago
MACD: Buy SignalNov 3, 9:30 AM1 hour ago
SMA: BearishNov 2, 3:55 PM18 hours ago
MACD: Sell SignalNov 2, 3:55 PM18 hours ago
SMA: BullishNov 2, 3:40 PM19 hours ago
SMA: BearishNov 2, 3:25 PM19 hours ago
SMA: BullishNov 2, 2:35 PM20 hours ago
SMA: BullishNov 2, 2:35 PM20 hours ago
SMA: BearishNov 2, 2:20 PM20 hours ago
SMA: BearishNov 2, 2:15 PM20 hours ago
SMA: BullishNov 2, 2:10 PM20 hours ago
MACD: Buy SignalNov 2, 2:05 PM20 hours ago
SMA: BullishNov 2, 2:00 PM20 hours ago
SMA: BearishNov 2, 1:25 PM21 hours ago
MACD: Sell SignalNov 2, 1:25 PM21 hours ago
SMA: BullishNov 2, 1:05 PM21 hours ago
SMA: BullishNov 2, 1:00 PM21 hours ago
MACD: Buy SignalNov 2, 1:00 PM21 hours ago
MACD: Sell SignalNov 2, 12:40 PM22 hours ago
SMA: BearishNov 2, 12:15 PM22 hours ago

Newest 20 of 116.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 122.33 +23.5% upside
Target (low)
110.00
Target (mean)
122.33
Target (high)
130.00
Ratings (0m) 18 17 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy16
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 18
  • 1 month ago 16
  • 2 months ago 17

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SYRE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.83521-1.53 – -0.67-0.15-456.8%00.0%14
Next quarter-0.87534-1.97 – -0.69-0.74-18.3%00.0%14
Current year-2.83-4.81 – -2.37-1.98-43.0%00.0%14
Next year-3.51-4.51 – -2.36-2.83-23.8%00.0%14

Upgrades and downgrades

The latest rating changes

SYRE analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026BTIGReiteratedBuyBuy
Oct 12, 2026UBSInitiated—Buy
Oct 1, 2026JP MorganInitiated—Overweight
Oct 1, 2026BTIGReiteratedBuyBuy
Sep 9, 2026WedbushReiteratedOutperformOutperform
Sep 8, 2026BTIGReiteratedBuyBuy
Aug 26, 2026Deutsche BankMaintainedBuyBuy
Aug 26, 2026WedbushMaintainedOutperformOutperform
Aug 26, 2026BTIGMaintainedBuyBuy
Aug 11, 2026BTIGMaintainedBuyBuy
Aug 5, 2026Wells FargoMaintainedOverweightOverweight
Aug 5, 2026GuggenheimMaintainedBuyBuy
Aug 5, 2026WedbushMaintainedOutperformOutperform
Jul 28, 2026Wolfe ResearchDowngradeOutperformPeer Perform
Jul 13, 2026MizuhoMaintainedOutperformOutperform
Jun 23, 2026Deutsche BankMaintainedBuyBuy
Jun 15, 2026BTIGMaintainedBuyBuy
Jun 4, 2026Deutsche BankMaintainedBuyBuy
May 6, 2026CitigroupMaintainedBuyBuy
May 6, 2026StifelMaintainedBuyBuy
Apr 17, 2026Jones TradingMaintainedBuyBuy
Apr 14, 2026Wells FargoMaintainedOverweightOverweight
Apr 14, 2026WedbushMaintainedOutperformOutperform
Apr 14, 2026BairdMaintainedOutperformOutperform
Apr 14, 2026Raymond JamesInitiated—Strong Buy
Apr 14, 2026Deutsche BankMaintainedBuyBuy
Apr 13, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 13, 2026JefferiesMaintainedBuyBuy
Apr 13, 2026BTIGMaintainedBuyBuy
Mar 31, 2026BTIGReiteratedBuyBuy